AINSLEE NOREEN: Open Payments
NPI 1316221286 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 16 payments from 10 companies in 2025. Trend: 2023 $1,350 · 2024 $798 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $72 |
| Janssen Biotech, Inc. | 2 | $51 |
| Dendreon Pharmaceuticals LLC | 2 | $45 |
| Ferring Pharmaceuticals Inc. | 2 | $44 |
| Boston Scientific Corporation | 2 | $41 |
| Telix Pharmaceuticals | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Blue Earth Diagnostics | 1 | $20 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
Products named: ERLEADA, BOTOX, PROVENGE, ADSTILADRIN, LUPRON DEPOT, ILLUCCIX, General - Male SUI, LYNPARZA.
Industry payments across NC — which companies pay providers there.
